Rodgers Brothers Inc. Gilead Sciences, Inc. Transaction History

Rodgers Brothers Inc.

$690 Million
Q2 2024

A detailed history of Rodgers Brothers Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Rodgers Brothers Inc. holds 3,758 shares of GILD stock, worth $331,004. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,758

Previous 3,738 0.54%

Holding current value

$331,004

Previous $273,000 5.86%

% of portfolio

0.04%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $1,263 - $1,457	20 Added 0.54%	3,758 $257,000
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $21,981 - $24,927	-300 Reduced 7.43%	3,738 $302,000
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $68,394 - $74,619	925 Added 29.71%	4,038 $302,000
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $10,489 - $11,964	138 Added 4.64%	3,113 $239,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $1.49 Million - $2.13 Million	-23,850 Reduced 88.91%	2,975 $255,000
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $83,356 - $95,214	-1,400 Reduced 4.96%	26,825 $1.66 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $11,544 - $13,002	-200 Reduced 0.7%	28,225 $1.75 Million
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $40,544 - $50,806	-700 Reduced 2.4%	28,425 $1.69 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $6,488 - $7,364	100 Added 0.34%	29,125 $2.12 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $13,538 - $14,606	200 Added 0.69%	29,025 $2.03 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $1.22 Million - $1.33 Million	19,150 Added 197.93%	28,825 $1.99 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $138,792 - $158,147	-2,450 Reduced 20.21%	9,675 $564,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $543,375 - $683,200	8,750 Added 259.26%	12,125 $766,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $72,340 - $84,000	-1,000 Reduced 22.86%	3,375 $260,000
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $1.25 Million - $1.6 Million	-19,975 Reduced 82.03%	4,375 $327,000
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $234,156 - $257,564	3,800 Added 18.49%	24,350 $1.58 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $9,280 - $10,407	150 Added 0.74%	20,550 $1.39 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $348,604 - $390,528	5,575 Added 37.61%	20,400 $1.33 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $93,837 - $122,450	-1,550 Reduced 9.47%	14,825 $927,000
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $26,730 - $29,595	375 Added 2.34%	16,375 $1.26 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $9,732 - $11,352	-150 Reduced 0.93%	16,000 $1.13 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $240,372 - $293,040	3,300 Added 25.68%	16,150 $1.22 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $71,150 - $83,520	1,000 Added 8.44%	12,850 $921,000
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $854,503 - $1.01 Million	11,850	11,850 $960,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rodgers Brothers Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rodgers Brothers Inc. with notifications on news.

Account

Rodgers Brothers Inc. Gilead Sciences, Inc. Transaction History